On July 30, Hims & Hers Health Inc. rose 5.16% in regular trading, trading at 26.545 USD/share, with turnover of $163 million. The stock staged a significant recovery from intraday lows after the company issued a strong rebuttal to a Federal Trade Commission lawsuit.

The U.S. Federal Trade Commission filed a lawsuit against Hims & Hers Health, alleging the company shared users' health data with Meta Platforms and Snap without consent, while also citing billing practices and subscription cancellation policy violations. The news initially sent shares plunging more than 12% during the session.

However, Hims & Hers responded decisively, declaring its position is firmly defensible and vowing to take aggressive legal action to combat what it characterized as entirely baseless allegations. The company stated that the lawsuit disregards substantial evidence it provided to the FTC over nearly three years of investigation. This forceful stance helped stabilize market sentiment, driving a sharp recovery from session lows.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)